Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

1.

Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, Kwasny W, Jakesz R, Fitzal F, Filipcic L, Fridrik M, Greil R, Gnant M.

Ann Surg Oncol. 2012 Jun;19(6):1808-17. doi: 10.1245/s10434-011-2189-y. Epub 2011 Dec 30.

PMID:
22207051
[PubMed - indexed for MEDLINE]
2.

Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA.

Eur J Surg Oncol. 2002 Aug;28(5):481-9.

PMID:
12217299
[PubMed - indexed for MEDLINE]
3.

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.

Wu SG, Chen Y, Sun JY, Li FY, Lin Q, Lin HX, He ZY.

Radiat Oncol. 2013 May 14;8:119. doi: 10.1186/1748-717X-8-119.

PMID:
23672513
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI.

Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8.

PMID:
19655200
[PubMed - indexed for MEDLINE]
5.

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese.

PMID:
18353207
[PubMed - indexed for MEDLINE]
6.

Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.

Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA.

Ann Surg Oncol. 1998 Mar;5(2):140-9.

PMID:
9527267
[PubMed - indexed for MEDLINE]
7.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group.

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
[PubMed - indexed for MEDLINE]
8.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
9.
10.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

PMID:
9231678
[PubMed - indexed for MEDLINE]
11.

lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.

Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.

PMID:
19289261
[PubMed - indexed for MEDLINE]
12.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
[PubMed - indexed for MEDLINE]
Free Article
13.

Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.

Duraker N, Demir D, Bati B, Yilmaz BD, Bati Y, Çaynak ZC, Sobutay E.

Jpn J Clin Oncol. 2012 Jul;42(7):601-8. doi: 10.1093/jjco/hys052. Epub 2012 Apr 17.

PMID:
22511807
[PubMed - indexed for MEDLINE]
Free Article
14.

Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.

Meric F, Mirza NQ, Buzdar AU, Hunt KK, Ames FC, Ross MI, Pollock RE, Newman LA, Feig BW, Strom EA, Buchholz TA, McNeese MD, Hortobagyi GN, Singletary SE.

Ann Surg Oncol. 2000 Jul;7(6):435-40.

PMID:
10894139
[PubMed - indexed for MEDLINE]
15.

Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up.

Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr.

J Am Coll Surg. 2010 May;210(5):797-805.e1, 805-7. doi: 10.1016/j.jamcollsurg.2010.02.045.

PMID:
20421053
[PubMed - indexed for MEDLINE]
16.

Lymph node ratio should be considered for incorporation into staging for breast cancer.

Chagpar AB, Camp RL, Rimm DL.

Ann Surg Oncol. 2011 Oct;18(11):3143-8. doi: 10.1245/s10434-011-2012-9. Epub 2011 Aug 17.

PMID:
21847696
[PubMed - indexed for MEDLINE]
17.

Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.

Yang C, Liu F, Li S, Li W, Zhai L, Ren M, Li Y, Lang R, Fan Y, Zhang X, Fu L.

Int J Surg Pathol. 2012 Dec;20(6):546-54. doi: 10.1177/1066896912451323. Epub 2012 Jun 25.

PMID:
22736300
[PubMed - indexed for MEDLINE]
18.

The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer.

Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G; Member of the International Nodal Ratio Working Group.

Eur J Cancer. 2008 Aug;44(12):1670-7. doi: 10.1016/j.ejca.2008.05.011. Epub 2008 Jul 1.

PMID:
18595686
[PubMed - indexed for MEDLINE]
19.

Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer.

Shimomura M, Ikeda S, Takakura Y, Kawaguchi Y, Tokunaga M, Egi H, Hinoi T, Okajima M, Ohdan H.

Surg Today. 2011 Oct;41(10):1370-9. doi: 10.1007/s00595-010-4446-2. Epub 2011 Sep 16.

PMID:
21922359
[PubMed - indexed for MEDLINE]
20.

Prognostic value of lymph node ratio in stage III colorectal cancer.

Wong KP, Poon JT, Fan JK, Law WL.

Colorectal Dis. 2011 Oct;13(10):1116-22. doi: 10.1111/j.1463-1318.2010.02435.x.

PMID:
20874800
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk